Aparito, based in Wrexham, has developed technology to transform the way that clinical trials are conducted. It improves the trial experience for patients and families by enabling patient data to be collected in real-time using wearable devices and disease-specific mobile apps. Its technology also benefits pharmaceutical companies by allowing richer, real-time clinical trial data to be collected remotely, saving time and cost.

The company raised £1.45 million from investors including Bethnal Green Ventures, Wealth Club, and the Development Bank of Wales. The funding is being used to hire key leadership and further develop its products. This has helped Aparito to secure new contracts and continue its expansion.